Skip to content
TaiRx, Inc. | New Drug Development Logo TaiRx, Inc. | New Drug Development Logo TaiRx, Inc. | New Drug Development Logo
  • About Us
    • Meet TaiRx
    • Vision
    • Innovation
    • Management Team
    • Scientific Advisory Committee
    • Board of Directors
  • Product Pipeline
    • CVM-1118
    • Zelnite®
    • TRX-NOC
    • TRX-920
    • TRX-105
  • Market Product
  • News
  • Contact Us
  • enEnglish
    • zh-hant繁體中文
News jeff 2018-05-31T11:46:02+00:00

News

TaiRx received Honorable award at the 2015 Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Award Competition.

2015/9/24 […]

Chang Lisa 2021-02-17T13:44:45+00:00 September 24th, 2015|News|
Read More

TaiRx received the Bronze Award at the 2015 Taipei Biotech Award Competition.

2015/7/24 Bio@Taipei [...]

Chang Lisa 2021-02-17T13:48:45+00:00 July 24th, 2015|News|
Read More

CVM-1118 IND approved by the US FDA to initiate Phase I clinical study in US.

2015/5/13 CVM-1118 from TaiRx, [...]

Chang Lisa 2018-06-04T17:51:46+00:00 May 13th, 2015|News|
Read More

TaiRx signed research contract with Northwestern University Ann & Robert H. Lurie Children’s Hospital of Chicago to evaluate Nodal, a novel oncology target

2014/3/14 […]

Chang Lisa 2018-06-04T17:51:53+00:00 March 14th, 2014|News|
Read More

TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.

2014/1/10  MoneyDJ [...]

Chang Lisa 2021-02-17T13:53:31+00:00 January 10th, 2014|News|
Read More
Previous456Next
Copyright© 2018 台睿生物科技股份有限公司 | 網頁設計公司:振作國際